Through collaboration with European health bodies, Global Health EDCTP3 aims to strengthen tuberculosis prevention and treatment, especially involving children and people with weakened immune systems
The Pandemic Antiviral Discovery Fund aims to mirror its vaccines counterpart CEPI, advancing drugs to phase II development to be ready for when the next pandemic strikes
The Coalition for Pandemic Preparedness played a key part in speeding development of COVID-19 vaccines. It now needs support over the next five years to end the pandemic and be ready for future infectious disease outbreaks
The EU and the African Union agreed on a new innovation agenda, but campaigners still believe the EU could do more to help Africa manufacture its own vaccines
With our handling of critical vaccine and gene technologies, we risk repeating the same disastrous mistakes of nuclear weaponry 75 years ago. Is it too late to learn from history?
Victor Dzau, President of US Academy of Medicine, calls on governments to establish a global health threats council, and says pharmaceutical companies should temporarily waive COVID-19 vaccine patents.
With vaccination rates on the up in Europe, universities are re-opening their campuses and preparing for face-to-face teaching. But the onus will be on students to show they are infection-free
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and the fortnightly R&D Express, tracking reforms and investments in central and eastern Europe.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.